Healthcare Industry News: Bovie
News Release - October 11, 2006
Bovie Medical Announces Exclusive Distribution Agreement with Boston Scientific for Electrosurgery Oncology ProductMELVILLE, N.Y.--(HSMN NewsFeed)--Bovie Medical Corporation ("Bovie") (AMEX:BVX ), a manufacturer and marketer of electrosurgical products, announced today that it has entered into an agreement with Boston Scientific Corporation (NYSE: BSX ) for the exclusive distribution and marketing by Boston Scientific of an electrosurgical device for use in Boston Scientific's Oncology business. Under the agreement, Bovie will manufacture the product. The product will be co-labeled with both the Boston Scientific and Bovie names displayed. Additionally, Bovie will receive funding from Boston Scientific as part of its manufacturing start up.
Commenting on the agreement, Bovie president Andrew Makrides stated, "We are pleased to be working with one of the premier medical device companies in the world. It is a strong step forward in our strategy to achieve greater market recognition through Boston Scientific's well-established and expert sales force. Bovie looks ahead to a continued mutually beneficial relationship with Boston Scientific."
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.
About Bovie Medical
Bovie Medical Corporation, headquartered in Melville, NY, with manufacturing in St. Petersburg, FL, is a developer, manufacturer and marketer of electrosurgical products. For more information, please visit: www.Boviemedical.com.
Source: Bovie Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.